| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.0083 | 0.8 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.008 | 0.8 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.8 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.8 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.8 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.8 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.007 | 0.8 |